Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in New Hyde Park, NY
NPI: 1285764670Primary Practice Location
NORTH SHORE UNIVERSITY HOSPITAL
300 Community Dr, Manhasset, NY
Primary Employer
Northwell Health Center for Advance Medicine
cancer.northwell.edu
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2001 - 2027
American Board of Internal Medicine
Medical Oncology
Tufts Medical Center
Fellowship • Hematology and Medical Oncology
1994 - 1998
Residency • Internal Medicine
1991 - 1994
UMass Chan Medical School
umassmed.edu
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 251 | 513 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 57 | 58 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 38 | 56 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 27 | 27 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 23 | 35 |
Authors: Benedict, Catherine, Thom, Bridgette, Teplinsky, Eleonora, Carleton, Jane, Kelvin, Joanne F
Journal: Clin Breast Cancer
Publication Date: 2016-12-24
Determining issues of importance for patients with breast cancer: Results of a web-based study in 1,072 patients to enhance the content validity for the development of a new health-related quality of life (QL) instrument, the Breast Cancer Symptom Scale (BCSS).
Authors: Horigan JL, Gralla RJ, Davis BJ, Hollen PJ, Petersen JA, Burg K, Belland A, Carleton J
Publication Date: 2009-05
Authors: James Jett, Primo Lara, Corey Langer, Heinz-Josef Lenz, Ronald Natale
Journal: J Clin Oncol
Publication Date: 2009-04-06
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: United States Department of Defense, National Cancer Institute (NCI), Bayer, Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Placebo, DRUG: Aspirin
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: Tamoxifen Citrate, DRUG: Systemic Chemotherapy
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI), Cancer and Leukemia Group B, North Central Cancer Treatment Group
Intervention / Treatment: DRUG: cisplatin, DRUG: irinotecan hydrochloride, DRUG: etoposide
